Completed PHASE1 INTERVENTIONAL 1-arm NCT01915771

Study to Determine the Intra-subject Variability of Pharmacokinetics of Lomitapide in Healthy Subjects

A Phase 1, Open-label, Crossover Study to Determine the Intra-subject Variability of the Pharmacokinetics of Single Oral CapsuleDose of 20 mg Lomitapide in Healthy Subjects

Sponsor: Aegerion Pharmaceuticals, Inc.

Conditions Intra-subject Variability of Pharmacokinetics

Interventions lomitapide

Updated 7 times since 2017 Last updated: Feb 25, 2020 Started: Jul 29, 2013 Primary completion: Aug 23, 2013 Completion: Aug 23, 2013

This information is for research purposes only and is not medical advice. Consult a healthcare provider before making any medical decision.

A PHASE1 clinical study on Intra-subject Variability of Pharmacokinetics, this trial is completed. The trial is conducted by Aegerion Pharmaceuticals, Inc. and has accumulated 7 data snapshots since 2013. Longitudinal tracking of this trial contributes to a broader understanding of treatment development timelines.

Status Flow

Change History

7 versions recorded

Sep 2024 — Present [monthly]

Completed PHASE1
Jul 2024 — Sep 2024 [monthly]

Completed PHASE1
Jan 2021 — Jul 2024 [monthly]

Completed PHASE1
Apr 2020 — Jan 2021 [monthly]

Completed PHASE1
Jun 2018 — Apr 2020 [monthly]

Completed PHASE1

▶ Show 2 earlier versions

Feb 2017 — Jun 2018 [monthly]

Completed PHASE1
Jan 2017 — Feb 2017 [monthly]

Completed PHASE1

First recorded

Jul 2013

Trial started

Per CT.gov start date — pre-dates our first snapshot

Eligibility Summary

No eligibility information available.

Contact Information

Sponsor contact:

Aegerion Pharmaceuticals, Inc.

Data source: Aegerion Pharmaceuticals, Inc.

For direct contact, visit the study record on ClinicalTrials.gov .

Study Locations

• Croydon, United Kingdom